NTLA(Intellia Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-02 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 9,000 | $11.99 |
| 2026-10-02 | Dube Michael P | VP, Chief Accounting Officer | 公开市场卖出 | 1,864 | $12.43 |
| 2026-08-21 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 2,785 | $13.00 |
| 2026-08-20 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 19,890 | $12.60 |
| 2026-07-22 | Dulac Edward J III | EVP, Chief Financial Officer | 公开市场卖出 | 8,111 | $11.25 |
| 2026-07-02 | Dulac Edward J III | EVP, Chief Financial Officer | 公开市场卖出 | 4,677 | $18.00 |
| 2026-07-01 | Dube Michael P | VP, Chief Accounting Officer | 公开市场卖出 | 2,641 | $16.78 |
| 2026-03-02 | BASTA JAMES | EVP, General Counsel | 公开市场卖出 | 1,211 | $13.78 |
| 2026-03-02 | Clark Eliana | EVP, Chief Technical Officer | 公开市场卖出 | 607 | $13.78 |
| 2026-01-05 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 34,146 | $9.21 |
| 2026-01-05 | Schultes Birgit C | EVP, Chief Scientific Officer | 公开市场卖出 | 8,508 | $9.21 |
| 2026-01-05 | BASTA JAMES | EVP, General Counsel | 公开市场卖出 | 10,397 | $9.21 |
| 2026-01-05 | Cohen Fred E | 董事 | 公开市场买入 | 150,000 | $9.35 |
| 2026-01-05 | Lebwohl David | EVP, Chief Medical Officer | 公开市场卖出 | 11,903 | $9.21 |
| 2026-01-05 | Clark Eliana | EVP, Chief Technical Officer | 公开市场卖出 | 9,515 | $9.21 |
| 2026-01-05 | Dulac Edward J III | EVP, Chief Financial Officer | 公开市场卖出 | 6,379 | $9.21 |
| 2026-01-05 | Dube Michael P | VP, Chief Accounting Officer | 公开市场卖出 | 2,989 | $9.21 |
| 2025-12-11 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 5,355 | $9.59 |
| 2025-12-11 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 32,832 | $9.47 |
| 2025-12-11 | LEONARD JOHN M | President and CEO | 公开市场卖出 | 49,959 | $9.49 |